Changes in tear fluid composition in dry eye disease: a literature review
- 4 July 2025
- journal article
- Published by Academy of Medical Optics and Optometry in The EYE GLAZ
- Vol. 27 (2) , 140-147
Abstract
Background. The global prevalence of dry eye disease (DED) continues to rise. Alterations in the composition of the tear film are a key factor in the development of this condition. In recent years, a growing body of evidence has emerged on the underlying mechanisms of DED pathogenesis, driven by increasing interest in tear fluid as a material for clinical and diagnostic studies. Purpose: to outline the main research directions concerning tear biomarkers of DED, as well as their role in prognosis, development of novel treatment approaches, and monitoring therapeutic effectiveness. Materials and methods. A literature search was conducted in PubMed for articles published from 2000 to 2024. The selection was carried out using a comprehensive sampling method with the following keywords: tear, dry eye disease, Sjögren’s syndrome, biomarkers, cytokines, oxidative stress, enzymes, extracellular vesicles, microRNAs, NETosis. A total of 60 articles were included in the review. Results. Literature data on tear composition changes in DED indicate the presence of both general inflammatory alterations and disease-specific features. The review summarizes findings on tear content changes involving oxidative stress markers, apoptosis-related factors, proteases and their inhibitors, cytokines, lipids, and nucleic acids. Tear hyperosmolarity is a hallmark of DED, contributing to the enhancement of inflammation, recruitment of neutrophils into the tear film, and the formation of neutrophil extracellular traps (NETs). Elevated levels of inflammation markers such as matrix metalloproteinase-9, lactoferrin, myeloperoxidase, and elastase are indicative of disease severity. Differences in tear composition between Sjögren-related and non-Sjögren DED have diagnostic potential. Furthermore, tear microRNAs show promise as severity markers and differential diagnostic tools in DED. Conclusion. Available literature convincingly demonstrates that tear components can serve as biomarkers for diagnostic, prognostic, and therapeutic monitoring purposes in dry eye disease. The investigation of DED biomarkers paves the way for personalized approaches to the treatment of this condition.Keywords
This publication has 55 references indexed in Scilit:
- Rapid and quantitative detection of tear MMP-9 for dry eye patients using a novel silicon nanowire-based biosensorBiosensors and Bioelectronics, 2022
- Neutrophils and neutrophil extracellular trap components: Emerging biomarkers and therapeutic targets for age-related eye diseasesAgeing Research Reviews, 2022
- Cathepsin S is a novel target for age-related dry eyeExperimental Eye Research, 2021
- Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression LevelsAmerican Journal of Ophthalmology, 2020
- TFOS DEWS II Report Executive SummaryThe Ocular Surface, 2017
- TFOS DEWS II pathophysiology reportThe Ocular Surface, 2017
- TFOS DEWS II Diagnostic Methodology reportThe Ocular Surface, 2017
- Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patientsExperimental Eye Research, 2015
- Tear Cathepsin S as a Candidate Biomarker for Sjögren's SyndromeArthritis & Rheumatology, 2014
- The origin and properties of extracellular DNA: From PAMP to DAMPClinical Immunology, 2012